OWC Pharmaceutical Research Corp (OWCP)

[Farmer7]

FOMX results could not prove a high enough efficacy in there phase 3 trials. With OWCP proving an efficacy of 70 percent against inflammatory markers in psoriasis, I can only speculate acne efficacy would at the very least duplicate that number, or even be much higher.

Ironically about the time our chairman was announced, a roadmap on there website was updated, it stated the following about the cream:

CREAM FOR SKIN DISEASES: Psoriasis first with possible ACNE, Basal cell carcinoma, Atopic dermatitis and more.

There's plenty of reasons here to hold a position your comfortable with for 2018 and beyond.